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Aim: To develop mucoadhesive liposomes by anchoring the polymer chitosan-thioglycolic acid 
(chitosan-TGA) to the liposomal surface to target intestinal mucosal membranes.
Methods: Liposomes consisting of phosphatidylcholine (POPC) and a maleimide-functionalized 
lipid were incubated with chitosan-TGA, leading to the formation of a thioether bond between 
free SH-groups of the polymer and maleimide groups of the liposome. Uncoated and newly 
generated thiomer-coated liposomes were characterized according to their size, zeta potential, 
and morphology using photon correlation spectroscopy and transmission electron micros-
copy. The release behavior of calcitonin and the fluorophore/quencher-couple ANTS/DPX 
(8-aminonaphthalene-1,3,6-trisulfonic acid/p-xylene-bis- pyridinium bromide) from coated and 
uncoated liposomes, was investigated over 24 hours in simulated gastric and intestinal fluids. To 
test the mucoadhesive properties of thiomer-coated and uncoated liposomes in-vitro, we used 
freshly excised porcine small intestine.
Results: Liposomes showed a concentration-dependent increase in size – from approximately 
167 nm for uncoated liposomes to 439 nm for the highest thiomer concentration used in this 
study. Likewise, their zeta potentials gradually increased from about -38 mV to +20 mV , clearly 
indicating an effective coupling of chitosan-TGA to the surface of liposomes. As a result of 
mucoadhesion tests, we found an almost two-fold increase in the mucoadhesion of coupled 
liposomes relative to uncoupled ones. With fluorescence microscopy, we saw a tight adherence 
of coated particles to the intestinal mucus.
Conclusion: Taken together, our current results indicate that thiomer-coated liposomes possess 
a high potential to be used as an oral drug-delivery system.
Keywords: thiomer, liposome, mucoadhesion, chitosan-thioglycolic acid, oral drug delivery
Introduction
The oral route of drug delivery is considered the most convenient route for patients 
and medics alike, since it allows for easy, painless administration, thus leading to a 
high patient compliance. Nevertheless, several drugs, particularly peptide and protein 
drugs, still have to be administered intravenously due to enzymatic degradation and/or 
low absorption in the gastrointestinal tract. Different delivery systems have been 
developed to enhance the oral bioavailability of such drugs, among them liposomes. 
Liposomes are lipid nanoparticles, which have already shown their potential as drug 
carriers to deliver sensitive drugs to specific targets.1–3 Although liposomes showed 
some problems with reproducibility when they were first developed as oral drug car-
riers, they seem to be promising delivery systems with a good biocompatibility and 
a high versatility.4,5 To improve the properties of liposomes for oral delivery, various 
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strategies have been designed, such as combining liposomes 
with permeation enhancers, or coating them with polymers 
like chitosan, carbopol, eudragit, or silica.6–11 Polymers used 
for this coating procedure provide an interesting characteristic 
for oral drug delivery: they interact with mucosal surfaces, 
thereby increasing the time the delivery system is trapped 
at the site of drug absorption. Longer et al first showed that 
a delayed gastrointestinal transit, as induced by bioadhesive 
polymers, has a high potential of increasing the oral bioavail-
ability of drugs.12 Hence, mucoadhesive delivery systems 
have been developed not only for oral but also for buccal, 
rectal, pulmonary, ocular, or nasal drug delivery.13–15
In the present study, we aimed to develop a novel delivery 
system for the oral application of drugs, based on the coating 
of liposomes with a specific class of polymers called thiomers. 
Thiomers are prepared by immobilizing agents with thiol groups, 
such as L-cysteine, thioglycolic acid, 6-mercaptonicotinic acid, 
or 2-imminothiolane HCl, on polymeric backbones like poly-
carbophil, chitosan, or sodium carboxymethylcellulose.16–21 
Their main advantage is the increase in mucoadhesion relative 
to unmodified polymers. Unmodified polymers interact with 
mucin   layers via non-covalent bonds, such as ionic interactions 
or hydrogen bonds, whereas thiomers are thought to form 
disulfide bridges with cysteine-rich subdomains of mucus 
glycoproteins.16   Furthermore, thiomers have been shown to 
act as permeation enhancers by temporarily opening tight 
junctions in a reversible manner, which could further enhance 
the uptake of drugs.22
The objective of this study was to investigate the possibility 
of taking chitosan-thioglycolic acid (chitosan-TGA) as a coat-
ing material for lipid nanoparticles. Chitosan has been chosen 
because of its biocompatibility, biodegradability, and safe 
toxicity profile.23 In contrast to a loose coupling of   chitosan 
to the liposomal surface, which is mostly achieved by ionic 
interactions between polymer and liposomes, we covalently 
anchored the thiolated chitosan to the liposome.24–26 We then 
investigated the morphology of the newly generated particles, 
as well as the influence of the polymer coating on the size 
and zeta potential of the liposomes, their release behavior, 
and their mucoadhesive properties.
Materials and methods
Materials
Palmitoyl-oleoyl-phosphatidylcholine (POPC); 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-
  maleimidomethyl)cyclohexane-carboxamide] (DOPE-MCC); 
and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-
(lissamine rhodamine B sulfonyl) were purchased from 
Avanti Polar Lipids (Alabaster, AL). Chitosan-thioglycolic 
acid (chitosan-TGA) – with a molecular weight of 77 kDa 
and 539 ± 57 µmol SH-groups/g polymer – was synthesized 
and provided by Thiomatrix (Innsbruck, Austria). Fluorescein 
isothiocyanat (FITC)-labeled calcitonin (32 amino acids; 
molecular weight: 3803.29 g/mol) was synthesized and 
provided by piCHEM (Graz, Austria). The phosphate buf-
fer (pH 7.4) used for mucoadhesion studies was purchased 
from Invitrogen (Darmstadt, Germany). All other chemicals 
were of reagent grade and purchased from Sigma-Aldrich 
(Vienna, Austria).
Preparation of liposomes
Stock solutions of POPC and DOPE-MCC were prepared in 
chloroform-methanol (2:1 v/v) and chloroform, respectively. 
Aliquots of both stock solutions were mixed to obtain a molar 
ratio of POPC:DOPE-MCC of 3:0.3 for the coupling of chi-
tosan-TGA. For control liposomes, pure POPC was used. To 
test mucoadhesive behavior, the fluorescent phospholipid 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine 
rhodamine B sulfonyl) was added to both phospholipid 
solutions, giving a final ratio of 3.3:0.01 (lipid to label). The 
organic solvent was evaporated under a stream of nitrogen to 
obtain a lipid film, which was dried overnight in a vacuum 
chamber to ensure complete removal of the organic solvent. 
Hydration of the dry lipid film was accomplished by adding 
10 mM phosphate buffer containing 150 mM NaCl, pH 7.4 
(PBS), to yield a final lipid concentration of 30 mg/mL. The 
lipid suspension was incubated for one hour at room tem-
perature with repeated vortexing. The resulting multilamellar 
vesicles were sized by freeze and thaw (six cycles), followed 
by extrusion through 200 nm polycarbonate membranes 
(Whatman Inc, Clifton, NJ) with a Mini-Extruder (Avanti 
Polar Lipids, Alabaster, AL).
To investigate the release from coated and uncoated 
  liposomes, the liposomes were loaded either with anionic flu-
orophore 8-aminonaphthalene-1,3,6-trisulfonic acid (ANTS) 
and the cationic quencher p-xylene-bis-pyridinium bromide 
(DPX), or with FITC-labeled calcitonin.   Hydration of the 
POPC/DOPE-MCC film was performed with 5.4 mg/mL of 
ANTS and 19 mg/mL of DPX in PBS, or with 200 µg/mL 
of FITC-calcitonin in PBS, followed by freeze and thaw and 
size extrusion, as described.
Coupling of chitosan-TGA
Coupling was accomplished by the formation of thioether 
bonds between free SH-groups of chitosan-TGA and func-
tionalized maleimide-groups of the liposome (see Figure 1). 
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Figure 1 Reaction scheme for the covalent coupling of chitosan-TGA to a maleimide-functionalized phospholipid to form a stable thioether bond. 
Abbreviations: DOPE-MCC, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimidomethyl)cyclohexane-carboxamide]; TGA, thioglycolic acid.
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Chitosan-TGA was synthesized according to the method 
described previously.17 Different amounts of polymer, which 
were dissolved in deionized water to achieve a concentration 
of 3 mg/mL, were added to liposomal suspensions, which 
were diluted via PBS to a concentration of 10 mg/mL, to 
obtain molar ratios of 1:6, 1:4, 1:2, 1:1, 2:1, 4:1, and 6:1 
(SH-groups:maleimide groups). The mixtures were incubated 
overnight under agitation at room temperature. Control lipo-
somes were treated the same way.
Ellman’s test
A photometric assay was performed to determine the amount 
of free SH-groups of chitosan-TGA according to a slightly 
modified version of the Ellman´s method.27 Briefly, the 
Ellman’s reagent 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB) 
was dissolved in water to a concentration of 7.5 mM and the 
pH was adjusted by adding NaHCO3. L-cysteine was used as 
standard substance and a standard curve was prepared in a 
concentration range from 1 to 80 µM. Samples and standard 
substance were diluted to 800 µl with phosphate buffer (100 
mM Na-phosphate, 15 mM NaCl, 1 mM EDTA; pH 7.4) 
followed by the addition of 200 µl DTNB-solution. The reac-
tion was allowed to proceed for 30 minutes at room tempera-
ture in the dark. The amount of SH-groups was determined by 
measuring the absorbance at 412 nm using a Hitachi U-2000 
spectrophotometer (Hitachi, Tokyo, Japan).
To determine the total amount of thiol groups after cou-
pling, samples with molar ratios of 4:1 and 6:1 (SH-groups 
to maleimide groups, respectively) were used. In addition 
to coupled liposomes, control liposomes, mixed with the 
same amount of polymer, were also measured. All samples 
were reduced prior to the Ellman’s test by adding 65 µL of 
freshly prepared 1% sodium borohydride (NaBH4) solution 
to 100 µL of liposomal suspension. After incubation for 
1 hour at room temperature under argon and agitation, excess 
NaBH4 was removed by adding the same amount of 1 M HCl. 
The Ellman’s test was accomplished as described; however, 
before measuring, the turbid liposomes had to be removed. For 
this purpose, centrifugal filter units with a cutoff of 10 kDa 
  (Millipore, Vienna, Austria) were used (swinging bucket rotor 
at 5000 g for 20 minutes at 4°C). The flow through (yellow-
colored reaction product) was transferred to a plastic cuvette 
and the absorbance was measured immediately.
Particle size determination
Particle size distribution was determined by photon cor-
relation spectroscopy using a Zetasizer 3000HSA (Malvern 
Instruments, Herrenberg, Germany), which operated with 
a 10 mW helium-neon laser at a wavelength of 632.8 nm. 
The scattered light was measured at an angle of 90° and 
the temperature was maintained at 25°C. Particle size was 
analyzed by calculating the auto correlation function of the 
detected intensity; the polydispersity index of the liposomal 
suspension was given by the width of the size distribution. 
Coupled and control liposomes were measured after diluting 
them to a final lipid concentration of 0.03 mg/mL with ultra-
pure water (USF ELGA, High Wycombe, UK).
Determination of the zeta potential
The zeta potential of coupled and control liposomes 
was determined using the Zetasizer Nano ZS (Malvern 
  Instruments) – according to the Helmholtz-Smoluchowski 
equation – from the mobility of the liposomes in an oscil-
lating electric field. Samples were diluted with a buffer 
containing 10 mM of Tris and 2 mM of CsCl (pH 7.0) to a 
lipid concentration of 0.3 mg/mL, and were measured using 
a folded capillary cell (Malvern Instruments).
Negative-staining transmission  
electron microscopy
A total of 10 µL of coated or uncoated POPC/DOPE-MCC 
liposomes (3 mg/mL) was placed on a carbon-over-Pioloform®-
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coated copper grid and incubated for 1 minute. The excess 
sample was blotted with filter paper and immediately replaced 
by 10 µL of staining agent, which was allowed to settle for 
2 minutes; then, it was blotted again. Ammoniummolybdate 
(5%), phosphotungstic acid (1%), and uranyl acetate (2%) 
were tried as staining agents. Visualization of the samples was 
performed using a Zeiss EM 902 transmission electron micro-
scope (Carl Zeiss Microscopy, Oberkochen, Germany) at an 
acceleration voltage of 80 kV . Digital images were made using 
a Proscan Slow Scan CCD camera at 1 × 1 K resolution.
Freeze fracture transmission  
electron microscopy
Coated and uncoated POPC/DOPE-MCC liposomes were 
mixed with 30% glycerol (v/v), frozen in liquid propane, 
and stored in liquid nitrogen until further use. Samples were 
fractured in a Balzers BAF400D freeze-etching apparatus 
(Balzers, Liechtenstein) under vacuum, with a pressure 
between 1.3 * 10-4 and 1.3 * 10-5 Pa. Replicas were produced 
by vacuum deposition of the surface with platinum and car-
bon and controlled with a quartz crystal thin-film monitor. 
To clean the replicas, they were put into a sodium hypochlo-
rite solution for about 3 hours and stored overnight in 50% 
NaOH. Before mounting them on an uncoated copper grid, 
replicas were washed with distilled water at least three times. 
Visualization of the grids was accomplished with the system 
already described, at an acceleration voltage of 50 kV .
Release studies using ANTS/DPX
Free ANTS/DPX was removed from ANTS/DPX-loaded lipo-
somes by size exclusion chromatography using a Sephadex 
G75 column (Amersham Biosciences, Uppsala, Sweden). 
Subsequently, liposomes were coupled with chitosan-TGA 
at a 4:1 molar ratio (SH-groups:maleimide groups), or 
diluted with the same amount of deionized water (uncoupled 
  liposomes). Release of ANTS/DPX from both liposomal sus-
pensions was determined in simulated gastric fluid (SGF; 1 L 
contained 2 g of sodium chloride, 3.2 g of pepsin, and 7 mL 
of hydrochloric acid; pH 1.2) and simulated intestinal fluid 
(SIF; 1 L contained 6.8 g of monobasic potassium phosphate, 
10 g of pancreatin, and 77 mL of 0.2 N sodium hydroxide; 
pH 6.8), which were prepared according to the US Pharma-
copeial Convention. Samples were diluted 1:1 with one of 
these simulated body fluids and incubated for 24 hours. At 
fixed time points, 60 µL of these mixtures was withdrawn, 
mixed with 2 mL of PBS, and measured fluorimetrically 
using a SPEX FLUOROMAX-3 fluorescence spectrometer 
(Jobin Yvon Horiba, Longjumeau Cedex, France) at an 
excitation wavelength of 360 nm and an emission wavelength 
of 530 nm. To determine the fluorescence corresponding to a 
100% release of ANTS/DPX, 10 µL of 10% Triton X-100™ 
was added to the cuvette before measuring.
Release studies using FITC-calcitonin
Purification and coupling of chitosan-TGA to FITC-  calcitonin-
loaded liposomes were performed in the same manner as for 
the ANTS/DPX-loaded liposomes. To determine the release 
of FITC-calcitonin from liposomes, a dialysis membrane was 
used to separate free from encapsulated peptide, as described 
previously by Saarinen-Savolainen et al.28 Briefly, 1 mL of 
freshly prepared drug-loaded liposomes, with or without 
chitosan-TGA coating, was mixed with 500 µL of SGF or 
SIF, respectively. The mixture was transferred to a dialysis 
bag (molecular cut-off: 300 kDa), which was put into 15 mL 
of PBS solution. The solution outside the bag was stirred with 
a magnetic stirrer to ensure a continuous movement of the 
buffer solution and a homogenous distribution of released 
FITC-calcitonin. Samples of 800 µL were withdrawn at fixed 
time intervals from the outer compartment and replaced 
immediately with equal volumes of PBS buffer solution. After 
24 hours of testing, 15 µL of 10% Triton X-100™ was added 
to the mixture inside the bag to disrupt the liposomes and 
release all of the entrapped peptide. This mixture was stirred 
for another 24 hours before determining the fluorescence of 
a 100% release. Samples were analyzed for FITC-calcitonin 
by measuring the fluorescence of 200 µL of the withdrawn 
solution at an excitation wavelength of 490 nm and an emis-
sion wavelength of 525 nm.
In-vitro mucoadhesion studies
For the mucoadhesion studies, we used a modified version 
of the falling liquid film technique previously described by 
Belgamwar et al.29 A freshly excised porcine small intestine 
was supplied by Karneta (Graz, Austria); 15 cm pieces were 
cut from the intestine and washed with physiological saline 
(37°C). The intestinal tube was cut longitudinally, and a 
5 × 9 cm excised sheet was placed on a semicylindrical 
Plexiglas® support with the mucosal side up (see Figure 2). 
The intestinal tissue was rinsed with 1 mL of rhodamine-
labeled POPC or thiomer-coated liposomes (4:1 molar 
ratio of SH-groups to maleimide groups) containing a total 
lipid amount of either 25 or 100 µg/mL. The excess was 
collected in a petri dish and reapplied. This procedure was 
repeated ten times and the fluorescence intensity of the 
final residual solution (It) was measured with a fluorim-
eter (FluoStar Galaxy; LABTECH, Offenburg, Germany) 
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Figure 2 Falling Liquid Film technique to measure the mucoadhesion of coated and uncoated liposomes.
at an excitation wavelength of 544 nm and an emission 
wavelength of 590 nm. A 96-well plate (Cellstar®, Greiner 
Bio-One GmbH, Friedrichshafen, Germany) was used 
throughout the study. The mean value of at least three mea-
surements was determined to calculate the amount of bound 
liposomes according to the following equation:
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where I0 is the fluorescence of the initial solution, V0 is the 
volume that is applied to the tissue; Vt is the final volume of 
the unbound solution; and Adhesive % corresponds to the 
adhesive fraction of the applied liposomal suspension.
Cell viability
To make sure that the intestinal tissues used for these experi-
ments were still viable, cell vitality assays were carried out using 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolinum bromide 
(MTT).30 Consequently, tissues were sliced into 5 mm samples 
after extensively washing them (n = 12). Half of the samples 
were boiled in water for 1 hour to inactivate the enzymes (zero 
value). All excidates were transferred to a 12-well plate con-
taining 2 mL of MTT solution (2 mg/mL), and were incubated 
for 2 hours at 37°C, 95% air/5% CO2 in the incubator. Subse-
quently, the MTT was removed and the samples were washed 
twice with 1 mL of PBS. The samples were then minced with 
scissors and the formazan precipitate was extracted in 4 mL of 
dimethyl sulfoxide for 80 minutes on a rotating platform (80 
rpm; Orbital Schuttler OD 10C; Al-Labortechnik, Amstetten, 
Austria). The formazan absorbance was recorded at 544 nm, 
with dimethyl sulfoxide as blank, on a plate reader.
Fluorescence microscopy
After the application of liposomes, the intestinal   tissue 
was incubated for 30 minutes at 37°C/95% air/5% CO2 and 
fixed with 4% formalin for 3–4 hours at room   temperature. 
  Tissues were embedded in Tissue Tec OCT (Sanova, 
Vienna,   Austria) and 10 µm sections were cut using a 
HM560   Cryostat (Thermo Scientific, Walldorf, Germany). 
To assess tissue penetration, bright field images and fluores-
cent images – with excitation BP 520–550 nm and emission 
LP 580 nm for red fluorescence – were acquired with an 
Olympus BX-51 microscope   (Olympus, Vienna,   Austria). 
Sections with tissue not exposed to liposomes (negative 
controls) were used to evaluate autofluorescence.
Cytotoxicity screening
Human colorectal adenocarcinoma cells were used for 
cytotoxicity testing; 2 × 104 cells/well were seeded 
24 hours before treatment in 96-well plates, exposed to 
thiomer-coated liposomes (4:1 molar ratio of SH-groups 
to malei  mide groups), and suspended in Dulbecco’s modi-
fied Eagle medium in concentrations of 0–1000 µg/mL. 
Exposures were performed at 37°C in a 95% air/5% CO2 
atmosphere, and two time points (4 and 24 hours) were 
evaluated.   Contamination with endotoxin was assessed 
via a PYROGENT® Ultra Gel Clot Limulus Amoebocyte 
Lysate Assay (LONZA, Vienna, Austria). Only low concen-
trations of endotoxin were detected at the highest sample 
concentration. Cytotoxicity was studied by formazan 
bioreduction (CellTiter 96® A  Queous Non-Radioactive 
Cell Proliferation Assay; Promega, Vienna,   Austria); ATP 
content (CellTiter-Glo Luminescent Cell Viability Assay; 
Promega); and membrane integrity (CytoTox-ONE™ 
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Homogeneous Membrane Integrity Assay; Promega), as 
previously described.31
Statistical analysis
Data are presented as mean ± standard deviation. Data sets 
were compared using Student’s t-test and differences were 
considered as significant at P , 0.05.
Results and discussion
Preparation and characterization  
of thiomer-coated liposomes
To develop lipid nanoparticles with improved mucoadhesive 
properties, we explored the potential of thiolated polymers to 
coat the surface of preformed liposomes. For this purpose, we 
used low-molecular-weight chitosan, which had previously 
been modified by thioglycolic acid, as described by Kast 
et al.17 Chitosan-TGA is characterized by 539 ± 57 µmol 
free-SH groups/g polymer and 72 ± 38 µmol disulfide 
bridges/g polymer. An earlier study showed that nanoparticles 
formulated by such thiolated chitosans revealed significantly 
higher mucoadhesive properties than unmodified chitosan 
nanoparticles.19 In the present study, we covalently linked 
some of the free SH-groups of chitosan-TGA to maleimide-
groups – provided by functionalized phospholipid molecules 
(DOPE-MCC) – which are part of the liposome bilayer and 
make approximately 10 mol% of total lipids (Figure 1). As 
controls, liposomes without functionalized phospholipids 
were incubated with the same amount of polymer.
Size distribution
The size of the unmodified particles was determined to be 
167 nm (n = 3) for POPC/DOPE-MCC liposomes and 195 nm 
(n = 3) for liposomes containing only POPC. The polydis-
persity index values were in the range of 0.1–0.2, displaying 
one homogeneous population of liposomes with a narrow size 
distribution. The difference in the size of POPC liposomes 
and POPC/DOPE-MCC liposomes is likely to be caused 
by the presence of the maleimide-group on the head region 
of the DOPE lipid. With an increasing amount of polymer, 
given by the molar ratio of SH-groups to maleimide-groups, 
the size of the POPC/DOPE-MCC liposomes gradually 
increased. Above a ratio of 2:1, the curve levels off and only 
small increases are detectable as more polymer is added 
(Figure 3). No significant change in size was detectable 
for control liposomes. The polydispersity of POPC/DOPE-
MCC liposomes increased after coupling to a value of ∼0.5 
compared with ∼0.2 for control liposomes. This indicates a 
more heterogeneous size distribution of coupled relative to 
uncoupled liposomes.
To test whether the increase in particle size was caused by 
one polymer chain binding to more than one liposome, or by 
intermolecular disulfide bridges between free SH-groups of 
the chitosan-TGA polymer coat, we added a reducing agent 
before measuring particle size. As we found no differences 
in the size values before and after reduction, size increase 
caused by disulfide formation is highly unlikely.
Zeta potential
To investigate the influence of the polymer coating on 
the surface charge of liposomes, the zeta potential was 
measured. The negatively charged phosphate group of the 
functionalized lipid is responsible for the highly negative 
zeta potential of uncoated POPC/DOPE-MCC liposomes, 
whereas control liposomes consisting only of POPC are 
roughly neutrally charged (Figure 4). The zeta potential of 
maleimide-  functionalized liposomes increased from -38 mV 
to +20 mV, with increasing polymer concentration. The 
polymer itself is positively charged, and coupling of 
the polymer to the liposome increased the potential of 
the resulting particle. After the addition of the smallest 
amount of polymer used in this study, a rapid increase in 
the zeta potential was observed. Then, the zeta potential 
slightly increased –   coinciding with the increasing amount 
of polymer – and became positive, reaching a plateau at a 
4:1 ratio of SH-groups to maleimide-groups. This observation 
confirms the results obtained from the size measurements, 
Without TC 1:6  1:4  1:2  1:1  2:1  4:1  6:1
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Figure 3 Particle size after the addition of different amounts of polymers (given by 
the molar ratio of SH-groups of the polymer to maleimide groups of the liposome) 
to POPC liposomes () and POPC/DOPE-MCC liposomes (). 
Note: Indicated values are means ± standard deviation of at least three measurements. 
Abbreviations: DOPE-MCC, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-
[4-(p-maleimidomethyl)cyclohexane-carboxamide];  POPC,  Palmitoyl-oleoyl-
phosphatidylcholine; TC, chitosan-thioglycolic acid.
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indicating a polymer saturation concentration. Therefore, 
a ratio of 4:1 was chosen for mucoadhesion and drug release 
studies. In contrast to POPC/DOPE-MCC liposomes, no 
change was measurable after adding different amounts of 
polymer to pure POPC liposomes.
To summarize, the change in the zeta potential from 
highly negative to positive values and the increase in the size 
of the liposomes by about 270 nm, led us to conclude that the 
polymer is successfully linked to the liposomal surface. This 
increase after coupling correlates well with the observations 
of other groups.32–35 The polymer is most likely bound to the 
liposomal surface by no other force than the covalent bond, 
since no effect of the polymer on the size or zeta potential 
of control liposomes could be detected.
Determination of free SH-groups
The amount of free SH-groups was measured after previous 
incubation of the samples with NaBH4 to reduce disulfide 
bridges, which may be formed between thiol groups. After 
coupling, we found 283 nmol free SH-groups/mg lipid, for 
a coupling ratio of 4:1 and about 494 nmol SH-groups/mg 
lipid, for a coupling ratio of 6:1 (SH-groups to maleimide 
groups) (see Table 1). When applied to the small intestine, 
the polymer, which is bound to the surface of liposomes after 
coupling, is able to interact with cysteine residues of mucus 
glycoproteins via freely available SH-groups. Consequently, 
thiomer-coated liposomes become covalently attached to the 
intestinal mucus by disulfide bridges. This should lead to an 
improved mucoadhesion of the particles.16
For maleimide-functionalized liposomes, we found 
∼100 nmol SH-groups/mg lipid less than for control liposomes. 
This reduction in the amount of free SH-groups after coupling 
is a strong indication for a successful binding of chitosan-
TGA to liposomes via maleimide groups. This difference of 
100 nmol SH-groups/mg lipid did not change by increasing 
the coupling ratio, as this difference represents the amount 
of maleimide groups in the sample, to which free SH-groups 
were coupled.
Liposome morphology
To study the morphology of coated and uncoated liposomes, 
negative staining transmission electron microscopy was 
chosen. Ammonium molybdate (5%), phosphotungstic acid 
(1%), and uranyl acetate (2%) were tried as staining agents. 
Uranyl acetate was found to give the best contrast and the 
most homogeneous distribution of the dye and was used 
for all further preparations. Pictures of uncoated liposomes 
showed mostly spherical liposomes (170–200 nm mean size). 
After adding the polymer, the liposomes were apparently 
linked with each other (Figure 5). With this technique, we 
were able to rule out the possibility that the increase in size 
of the liposomes, after adding the polymer, was caused by 
fusion. Nevertheless, we were not able to detect the polymer 
coat itself in negative-contrasted samples. Therefore, freeze 
fracturing was used to reveal the polymer coat (Figure 6). 
Drying and staining steps, during which the liposomes may 
suffer from different pH or salt conditions, are not neces-
sary; however, images prepared by freeze fracturing do not 
reflect the real size of the liposomes, since fracturing does 
not have to occur through the center of the particles.36 The 
freeze fractures of the coated samples clearly revealed the 
presence of the polymer at the periphery of the liposomes, 
which is marked by arrows in Figure 6B. Although no 
association of liposomes was found in uncoated samples 
(Figure 6A), single liposomes – as well as aggregates, 
which involve about three to ten liposomes – were visible 
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Figure 4 Zeta potential after the addition of different amounts of polymers (given by 
the molar ratio of SH-groups of the polymer to maleimide groups of the liposome) 
to POPC liposomes () and POPC/DOPE-MCC liposomes ().
Note: Indicated values are means ± standard deviation of at least three measurements.
Abbreviations: DOPE-MCC, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-
N-[4-(p-maleimidomethyl)cyclohexane-carboxamide]; POPC, Palmitoyl-oleoyl-
phosphatidylcholine; TC, chitosan-thioglycolic acid.
Table 1 Amount of SH-groups after coupling
Coupled  
liposomes 
4:1
Control  
liposomes 
4:1
Coupled  
liposomes 
6:1
Control  
liposomes 
6:1
Amount of  
SH-groups 
(nmol/mg  
total lipid)
283 ± 40 382 ± 19 494 ± 29 594 ± 12
Notes: Coupled liposomes (POPC/DOPE-MCC) with a coupling ratio (SH-groups 
to maleimide groups) of 4:1 and 6:1, and control liposomes (POPC) with the same 
amount of polymer solution added. All values are means ± standard deviation of 
five experiments.
Abbreviations: DOPE-MCC, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-
N-[4-(p-maleimidomethyl)cyclohexane-carboxamide]; POPC, Palmitoyl-oleoyl-
phosphatidylcholine.
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Figure 5 Transmission electron micrographs with negative staining technique of (A) uncoated POPC/DOPE-MCC liposomes and (B) POPC/DOPE-MCC liposomes coated 
with chitosan-TGA (4:1 molar ratio of SH-groups to maleimide groups). 
Notes: Magnification: 30,000×. Scale bar indicates 200 nm. 
Abbreviations: DOPE-MCC, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimidomethyl)cyclohexane-carboxamide]; POPC, Palmitoyl-oleoyl-phosphatidylcholine; 
TGA, thioglycolic acid.
Figure 6 Transmission electron micrographs using freeze fracturing of (A) uncoated POPC/DOPE-MCC liposomes and (B) POPC/DOPE-MCC liposomes coated with 
chitosan-TGA (4:1 molar ratio of SH-groups to maleimide groups). 
Notes: Arrows indicate the polymer coat. Magnification: 30,000×. Scale bar indicates 200 nm. 
Abbreviations: DOPE-MCC, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimidomethyl)cyclohexane-carboxamide]; POPC, Palmitoyl-oleoyl-phosphatidylcholine; 
TGA, thioglycolic acid.
in the coated sample (Figure 6B). Henriksen et al observed 
equally heterogeneous aggregates after adding negatively 
charged liposomes to a chitosan solution using cryo-electron 
microscopy.35 This heterogeneity is also reflected in the poly-
dispersity index of the size measurements, which increased 
with increasing the amount of polymer.
Aggregates between liposomes and the polymer can be 
formed by different mechanisms. One possibility is that one 
polymer chain binds to different liposomes, thereby cross-
linking single particles. This mechanism was also proposed 
by Mertins et al,37 where they bound chitosan to preformed 
liposomes by ionic interactions. Another possibility would 
be an entanglement of polymer chains that were previously 
bound to different liposomes. Disulfide formation has already 
been ruled out, as previously stated. Neither negative staining 
nor freeze-fracture electron microscopy allowed us to differ-
entiate between these scenarios. However, since aggregates 
are still present at very high dilutions, the first mechanism 
is more likely.
Drug encapsulation and release
To study drug loading and release profiles of thiomer-coated 
liposomes, we tested two different model drug systems. First, 
the fluorophore/quencher couple ANTS/DPX was used. 
Second, the fluorescent-labeled peptide calcitonin (FITC-
calcitonin) was encapsulated with an entrapment efficiency 
of 21.5%, which gave a final peptide concentration of 1.4 µg/
mg lipid.
The ANTS/DPX assay is usually performed to measure 
the influence of different agents on membrane stability.38 
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Hence, this system seems very suitable to quantify drug 
release.39 In principle, both the fluorophore ANTS and the 
quencher molecule DPX are encapsulated in liposomes 
  during the hydration step. The molecules are in close proxim-
ity to each other and the short distance between the quencher 
and fluorophore leads to a quenching of the latter; conse-
quently, the monitored fluorescence intensity is low. Upon 
leakage and release of ANTS/DPX, the fluorescence intensity 
increases in a concentration-dependent manner. With this 
technique, we could monitor the release profile from coupled 
and uncoupled liposomes at different environmental condi-
tions. In particular, we investigated the release properties in 
simulated gastric and intestinal fluids. Released ANTS/DPX 
can be measured at fixed time points without separating the 
released fluorophore. In the second model drug system, we 
separated released from encapsulated FITC-calcitonin by 
dialysis before measuring the fluorescence.
The release of ANTS/DPX (Figure 7) corresponded well 
with the release of FITC-calcitonin (Figure 8); albeit, the 
release of FITC-calcitonin in SGF was slightly higher than 
the release of ANTS/DPX in the same medium.   Comparing 
the release within the first 2 hours, it was for all tested lipo-
somes and model drugs in both SGF and SIF about 25%–
30%. Even though there was no significant difference in the 
release profiles of model drugs within the first few hours, 
we observed a slightly higher release from thiomer-coated 
liposomes after 24 hours (Figures 7 and 8). To further inves-
tigate this effect, coupled and uncoupled liposomes contain-
ing either ANTS/DPX or FITC-  calcitonin were kept in PBS 
and measured after 24 hours. For ANTS/DPX, the released 
fraction was 38% for coated liposomes compared with 
10% for uncoated liposomes, which were just mixed with 
water. The release behavior of FITC-calcitonin was similar, 
showing 39% and 13% for coated and uncoated liposomes, 
respectively. In both cases, a higher release of encapsulated 
compounds was found for thiomer-coated liposomes in the 
buffer. Polymer linkage apparently induced this increased 
release, suggesting the occurrence of some defects in the 
bilayer, which could be explained by force being exerted on 
phospholipid head-groups by intermolecular crosslinking. 
These results suggest that coated liposomes are, by them-
selves, more leaky, due to the polymer coat. Nonetheless, 
they are not less stable in simulated body fluid than uncoated 
ones. Nevertheless, neither coated nor uncoated liposomes 
released the encapsulated compounds abruptly, nor were 
they immediately disrupted by the enzymes – a fact that is 
crucial for a sustained release system.
In vitro mucoadhesion
To mimic physiological conditions for all experiments, the 
viability of the membrane, which represents a key parameter 
for reproducible data, was evaluated. The results revealed 
that the viability decreased as time increased, indicating 
that the mucosa has to be used immediately. The mucoad-
hesiveness of surface-modified liposomes was investigated 
using the falling liquid film technique (see Figure 2). By 
measuring the fluorescence of the particle solution before 
and after applying it to the mucus of the porcine small 
intestine, we could determine differences in the mucoad-
hesion of   chitosan-TGA-coated and uncoated liposomes. 
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Figure 7 Release of ANTS/DPX at predetermined time points from uncoated POPC/DOPE-MCC liposomes () and coated POPC/DOPE-MCC liposomes (4:1 molar ratio 
of SH-groups to maleimide groups) () in simulated gastric fluid (A) and simulated intestinal fluid (B).
Note: Each point represents the mean value of two different determinations. 
Abbreviations: ANTS, anionic fluorophore 8-aminonaphthalene-1,3,6-trisulfonic acid; DOPE-MCC, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimidomethyl)
cyclohexane-carboxamide]; DPX, p-xylene-bis-pyridinium bromide; POPC, Palmitoyl-oleoyl-phosphatidylcholine.
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  Thiomer-coated liposomes showed a ∼1.8-fold higher 
mucoadhesive effect relative to the uncoated lipsomes. The 
improvement ratio of coated to uncoated liposomes was not 
significantly different, whether 25 or 100 µg of liposomes 
was added to the tissue (Table 2A and B).
To visualize the adhered liposomes, the treated   tissues were 
viewed by fluorescence microscopy (Figure 9). The results 
demonstrate that tissues incubated with coated liposomes 
clearly showed a higher concentration of   rhodamine-labeled 
particles than tissues exposed to uncoated liposomes. Addi-
tionally, we observed a tight adherence of the coated liposomes 
to the surface of the intestinal mucus. The fluorescence micro-
scopic images illustrate that the intestinal tissue seems to be 
affected by the procedure; via formalin fixation and paraffin 
embedding, we could show that the integrity of the epithelial 
layer is preserved (data not shown).
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Figure 8 Release of FITC-calcitonin at predetermined time points from uncoated POPC/DOPE-MCC liposomes () and coated POPC/DOPE-MCC liposomes (4:1 molar 
ratio of SH-groups to maleimide groups) () in simulated gastric fluid (A) and simulated intestinal fluid (B). 
Note: Results are means ± standard deviation (n = 3). 
Abbreviations: DOPE-MCC, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimidomethyl)cyclohexane-carboxamide]; POPC, Palmitoyl-oleoyl-phosphatidylcholine.
Table 2 Percentage of uncoated/coated liposomes bound to the 
tissue after using the falling liquid film technique
Mucoadhesion  
of coated  
liposomes (%)
Mucoadhesion  
of uncoated  
liposomes (%)
Improvement   
ratio
(A) 25 μg/mL
70.4 33.5 2.1
68.4 46.1 1.5
61.3 41.7 1.5
(B) 100 μg/mL
56.6 31.4 1.8
60.3 45.0 1.3
60.0 26.0 2.3
Notes:  Comparison  of  three  independent  tests;  1  mL  of  coated  or  uncoated 
liposomes with a concentration of (A) 25 µg/mL or (B) 100 µg/mL was applied to 
the tissue and the amount of bound particles was calculated as a percentage (%) of 
the total.
Although various groups could show a strong electro-
static interaction between chitosan and liposomes, a covalent 
bond is generally considered more stable than electrostatic 
surface interactions. In terms of mucoadhesion, this might 
be advantageous, since the whole liposome-polymer com-
plex is bound to the mucosal membrane. The observed 
positive zeta potential of thiomer-coated liposomes could 
also contribute to an improved mucoadhesion due to ionic 
interactions between the positively charged polymer and 
the negatively charged constituents of the mucus layer; that 
is, sulfonic and sialic acid residues.40,41 Moreover, thiolated 
polymers, such as the chitosan-TGA used for our experi-
ments, form disulfide bridges with cysteine-rich subdomains 
of mucus glycoproteins.5 Thus, thiomer-coated liposomes 
can be attached covalently to the intestinal mucus, where 
the encapsulated compound is sustainedly released, as was 
shown by our release studies. Even though electrostatically 
chitosan-coated liposomes show a high mucoadhesion42,43 
it is hard to judge whether the polymer stays attached to 
the liposomal surface throughout the whole gastrointes-
tinal transit.
Cytotoxicity screening
For the assessment of cytotoxicity, the metabolic functions, 
according to formazan bioreduction and cellular ATP con-
tent, were determined. In addition, cell membrane integrity 
was assessed by the release of lactate dehydrogenase. In all 
three assays (up to 1 mg/mL of thiomer-coated liposomes), 
no indication of cellular damage was seen after incubation 
for 4 and 24 hours. Consistent with these results, cell mem-
brane integrity, which was verified by the absence of lactate 
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dehydrogenate release, was maintained. Taken together, these 
results demonstrate the absence of cytotoxic effects in the 
concentration range tested.
Conclusion
A novel delivery system, based on the coating of liposomes 
with thiolated chitosan, has been successfully synthesized and 
characterized. In contrast to the common coating procedure, 
in which polymers are attached to liposomes by ionic interac-
tions, we have established a covalent thioether bond between 
chitosan-TGA and the liposome. This covalent coupling was 
confirmed by size and zeta potential measurements, as well as 
negative-staining transmission electron microscopy images. In 
vitro mucoadhesion studies of thiomer-coated and uncoated 
liposomes showed that the residence time on porcine small 
intestine could be almost doubled by the addition of the poly-
meric layer around the liposome. Based on these investiga-
tions, we propose that coating liposomes with chitosan-TGA 
represents a promising strategy to create a mucoadhesive oral 
delivery system for sustained drug release.
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